Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive BiomarkersVivian Wai Yan Lui, Jennifer R. Grandis, Matthew L. Hedberg et al.|Cancer Discovery|2013Cited by 590
Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next‐generation sequencing assayYuri E. Nikiforov, Marina N. Nikiforova, Sally E. Carty et al.|Cancer|2014Cited by 502
Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance CytologyYuri E. Nikiforov, Marina N. Nikiforova, Sally E. Carty et al.|Thyroid|2015Cited by 393
Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutationsYvonne Y. Li, Kwok Wai Lo, Grace Tin‐Yun Chung et al.|Nature Communications|2017Cited by 336
First-in-Human Trial of a STAT3 Decoy Oligonucleotide in Head and Neck Tumors: Implications for Cancer TherapyMalabika Sen, Jennifer R. Grandis, Sufi M. Thomas et al.|Cancer Discovery|2012Cited by 313